These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38833042)

  • 1. METTL3-modified lncRNA DSCAM-AS1 promotes breast cancer progression through inhibiting ferroptosis.
    Yan Z; Liang Z; Luo K; Yu L; Chen C; Yu M; Guo X; Li M
    J Bioenerg Biomembr; 2024 Aug; 56(4):451-459. PubMed ID: 38833042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis.
    Yao F; Zhao Y; Wang G; Zhao M; Hong X; Ye Z; Dong F; Li W; Deng Q
    Cell Signal; 2024 Aug; 120():111221. PubMed ID: 38729321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SLC7A11-AS1/SLC7A11 pair as a ferroptosis-related therapeutic target for hepatocellular carcinoma.
    Yuan X; Wang Y; Jiao S; Gao H; Zhang M; Wang X; Zhou X; Wu C; Bao J
    J Cell Mol Med; 2024 Jul; 28(13):e18496. PubMed ID: 38984939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POU2F2-mediated upregulation of lncRNA
    Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
    Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 7. M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer.
    Cai Y; Zheng H; Xu D; Xie J; Wang W; Liu Z; Zheng Z
    Pharmacology; 2024; 109(5):282-292. PubMed ID: 38744264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 9. Methyltransferase Like-3-Mediated N6-Methyladenosine Modification of Long Noncoding RNA Hepatocyte Nuclear Factor 1a Antisense RNA 1/Hepatocyte Nuclear Factor 4a Antisense RNA 1 Regulates Cytochrome P450 Enzyme Expression.
    Yu Y; Wang J; Xiong Z; Du A; Wang X; Wang Y; Han S; Wang P; Zhang L
    Drug Metab Dispos; 2024 Sep; 52(10):1104-1114. PubMed ID: 39168523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Bian Y; Xu S; Gao Z; Ding J; Li C; Cui Z; Sun H; Li J; Pu J; Wang K
    Cancer Lett; 2024 Aug; 596():217004. PubMed ID: 38838765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling.
    Zhang Y; Guo S; Wang S; Li X; Hou D; Li H; Wang L; Xu Y; Ma B; Wang H; Jiang X
    Ecotoxicol Environ Saf; 2021 Sep; 220():112376. PubMed ID: 34051661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.
    Ma Y; Bu D; Long J; Chai W; Dong J
    J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N
    Ren Z; Hu Y; Sun J; Kang Y; Li G; Zhao H
    Bioengineered; 2022 Apr; 13(4):7963-7973. PubMed ID: 35356854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL14-Mediated m6A Modification of
    Gu X; Song Y; Liu X; Cheng Z; Min J; Zhang Y
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):298. PubMed ID: 39206905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M
    Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
    Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Xue L; Li J; Lin Y; Liu D; Yang Q; Jian J; Peng J
    J Cell Physiol; 2021 Apr; 236(4):2649-2658. PubMed ID: 32892348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3-driven m6A modification of lncRNA FAM230B suppresses ferroptosis by modulating miR-27a-5p/BTF3 axis in gastric cancer.
    Cui Y; Pu M; Gong Y; Li R; Wang X; Ye J; Huang H; Liao D; Yang Y; Yin A; Li J; Deng Y; Tian Z; Pu R
    Biochim Biophys Acta Gen Subj; 2024 Nov; 1868(11):130714. PubMed ID: 39278369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DSCAM-AS1: A Pivotal Therapeutic Target in Cancer.
    Hu C
    Mini Rev Med Chem; 2023; 23(5):530-536. PubMed ID: 35996247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
    Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.